Molecular conjugates comprising an antigen linked to a monoclonal antibody which binds to human Dendritic and Epithelial Cell 205 receptor (DEC-205) are provided. Also provided are isolated monoclonal antibodies which bind to human DEC-205, as well as pharmaceutical compositions and the use of the compositions in therapeutic and diagnostic methods.